Please login to the form below

Not currently logged in
Email:
Password:

PRA expands its European operations with new UK and Dutch offices

Will open new base in Utrecht and relocate its existing Reading, UK offices to a larger site

PRA is expanding its European operations and plans to open a new base in Utrecht in the Netherlands and relocate its existing Reading, UK office to a larger site.

The contract research organisation's (CRO) new Dutch facility will be home to over 20 employees and primarily support product registration trials – the first PRA office to have this focus.

The company's product registration staff had previously been either home-based or have shared facilities with colleagues based in Mechelen in Belgium.

“But to better share best practices among employees, we felt that it was now necessary to provide a permanent office for the increasing Dutch product registration team,” said PRA's Frank van de Wijngaert, vice president and general partner.

Meanwhile, PRA is also relocating over 240 employees based in Reading in the UK to a larger purpose build facility that offers additional room for increasing headcounts and provides modern facilities for client and project team meetings.

The CRO has recently signed a number of major deals, including a biosimilar research agreement with Amgen and global drug development partnership with UCB, and has been expanding of late.

PRA has opened nine new offices in Europe since 2009, including a Romanian base in August 2011, and it also opened new Singapore offices earlier this year.

22nd May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics